Physician profile
Lee A Brock
NPI 1336126036
$4,506.55
in general payments reported to CMS, 2019-2025
44 companies · $661 in 2025
The $661 reported for 2025 was more than what 92% of Anesthesiology providers received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,185 · 2020: $300 · 2021: $369 · 2022: $524 · 2023: $685 · 2024: $782 · 2025: $661.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,128.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,128.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $941.09 | 2019-2025 | General - Pain Management, Wavewriter Alpha Prime 16 |
| Abbott Laboratories | $362.60 | 2019-2024 | Proclaim |
| Abbvie INC. | $352.29 | 2022-2025 | Ubrelvy, Qulipta, Botox |
| Daiichi Sankyo INC. | $324.76 | 2019 | |
| Collegium Pharmaceutical, INC. | $309.11 | 2019-2025 | Xtampza |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $263.94 | 2022-2025 | Relistor |
| Medtronic, INC. | $195.62 | 2022-2025 | Intellis Adaptivestim, Inceptiv |
| Pacira Pharmaceuticals Incorporated | $179.08 | 2023-2024 | Exparel, Iovera, Zilretta |
| Pfizer INC. | $146.52 | 2019-2024 | |
| Forte Bio-Pharma LLC | $124.59 | 2020-2021 | |
| Curonix LLC | $97.95 | 2024 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Protega Pharmaceutials INC | $87.95 | 2025 | Roxybond |
| Horizon Therapeutics Plc | $86.59 | 2019-2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $74.16 | 2022 | |
| Spinal Simplicity, LLC | $73.21 | 2025 | Ha Minuteman G3-R |
Show all 44 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lee Brock listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.